PHA-543613 preserves blood-brain barrier integrity after intracerebral hemorrhage in mice.
Stroke
; 44(6): 1743-7, 2013 Jun.
Article
em En
| MEDLINE
| ID: mdl-23613493
ABSTRACT
BACKGROUND AND PURPOSE:
Blood-brain barrier disruption and consequent vasogenic edema formation codetermine the clinical course of intracerebral hemorrhage (ICH). This study examined the effect of PHA-543613, a novel α7 nicotinic acetylcholine receptor agonist, on blood-brain barrier preservation after ICH.METHODS:
Male CD-1 mice, subjected to intrastriatal blood infusion, received PHA-543613 alone or in combination with α7 nicotinic acetylcholine receptor antagonist methyllycaconitine or phosphatidylinositol 3-kinase inhibitor wortmannin.RESULTS:
PHA-543613 alone, but not in combination with methyllycaconitine or wortmannin, inhibited glycogen synthase kinase-3ß, thus, stabilizing ß-catenin and tight junction proteins, which was paralleled by improved blood-brain barrier stability and ameliorated neurofunctional deficits in ICH animals.CONCLUSIONS:
PHA-543613 preserved blood-brain barrier integrity after ICH, possibly through phosphatidylinositol 3-kinase-Akt-induced inhibition of glycogen synthase kinase-3ß and ß-catenin stabilization.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Quinuclidinas
/
Barreira Hematoencefálica
/
Transdução de Sinais
/
Hemorragia Cerebral
/
Receptores Nicotínicos
/
Compostos Bicíclicos Heterocíclicos com Pontes
Limite:
Animals
Idioma:
En
Revista:
Stroke
Ano de publicação:
2013
Tipo de documento:
Article
País de afiliação:
Estados Unidos